These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6186066)

  • 1. A, B, O (H) antigenic determinants in superficial transitional cell tumors of bladder.
    Selli C; Cozzolino F; Vercelli D; Mincione GP
    Urology; 1983 Feb; 21(2):132-4. PubMed ID: 6186066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
    Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
    J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic indicators of prognosis in bladder cancer: the importance of cell surface antigens.
    Richie JP; Blute RD; Waisman J
    J Urol; 1980 Jan; 123(1):22-4. PubMed ID: 6985979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A, B, H antigens in transitional cell tumors of the urinary bladder: correlation with the clinical course.
    Limas C; Lange P; Fraley EE; Vessella RL
    Cancer; 1979 Dec; 44(6):2099-107. PubMed ID: 509389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer.
    Vafier JA; Javadpour N; Worsham GF; O'Connell KJ
    Urology; 1984 Apr; 23(4):348-51. PubMed ID: 6369713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red cell surface antigen and its relationship to survival of patients with transitional cell carcinoma of the bladder.
    Askari A; Colmenares E; Saberi A; Jarman WD
    J Urol; 1981 Feb; 125(2):182-4. PubMed ID: 7206050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of the cell surface antigens with stage and grade in cancer of the bladder.
    Emmott RC; Javadpour N; Bergman SM; Soares T
    J Urol; 1979 Jan; 121(1):37-9. PubMed ID: 759641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface A, B, or O(H) blood group antigens as an indicator of malignant potential in stage A bladder carcinoma.
    Newman AJ; Carlton CE; Johnson S
    J Urol; 1980 Jul; 124(1):27-9. PubMed ID: 7411715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A B H isoantigens in bladder cancer. Preliminary study].
    Hernáez Manrique I; Rodríguez Trinidad A; Gastaminza A; Recarte Mendiluce JM
    Actas Urol Esp; 1983; 7(2):113-6. PubMed ID: 6880907
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of urine cytology with ABO(H) antigenicity in transitional cell carcinoma of the bladder.
    Das G; Glashan RW
    J Clin Pathol; 1988 May; 41(5):538-9. PubMed ID: 3384984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue blood-group antigens and prognosis in low stage transitional cell carcinoma of the bladder.
    Lange PH; Limas C; Fraley EE
    J Urol; 1978 Jan; 119(1):52-5. PubMed ID: 621815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic detection and prognosis of patients with transitional cell carcinoma of the urinary bladder.
    Tan LB; Lin LM; Huang CH; Chiang CP; Chien CH; Pan CC
    Urol Int; 1989; 44(5):264-71. PubMed ID: 2800062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical demonstration of blood group antigens in neoplastic and normal human urothelium: a comparison with standard red cell adherence.
    Flanigan RC; King CT; Clark TD; Cash JB; Greenfield BJ; Sniecinski IJ; Primus FJ
    J Urol; 1983 Sep; 130(3):499-503. PubMed ID: 6350617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Specific erythrocyte adherence reaction: an index of the malignant potentials of noninvasive tumors of the human urothelium].
    Anichkov NM; Anichkova SI
    Vopr Onkol; 1980; 26(8):9-13. PubMed ID: 7415061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specific red cell adherence test in transitional cell carcinoma of the bladder before and after radiotherapy in patients with blood group A.
    Wolk FN; Bishop MC
    J Urol; 1983 Jul; 130(1):71-3. PubMed ID: 6345808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modified immunoperoxidase method for the detection of ABH tissue isoantigens in patients with bladder carcinoma.
    Stul MS; Logghe GN; Bergmans GB; Vanvuchelen JK
    Exp Pathol; 1985; 27(2):119-22. PubMed ID: 3888650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A, B and O(H) isoantigens in tumor of the urinary bladder. Preliminary results, relating the specific red cell adherence test to pathological grade and stage.
    Karlsen S; Jordfald G; Svaar H
    Urol Int; 1984; 39(3):150-3. PubMed ID: 6740805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on blood group isoantigens in uroepithelium. I. Determination of isoantigens in non-malignant epithelium of tumor-bearing bladder].
    Abe R
    Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):1049-58. PubMed ID: 4079195
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison between the methods of indirect immunofluorescence and specific red cell adherence in detecting ABH iso-antigens in bladder carcinoma.
    Cooper HS; D'Elia FL
    Am J Clin Pathol; 1982 May; 77(5):548-54. PubMed ID: 7044101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoperoxidase detection of carcinoembryonic antigen and blood group substances in papillary transitional cell carcinoma of the bladder.
    Wiley EL; Mendelsohn G; Droller MJ; Eggleston JC
    J Urol; 1982 Aug; 128(2):276-80. PubMed ID: 7050419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.